 |
|
CLINICIAN'S CORNER
Adrenoleukodystrophy
New Approaches to a Neurodegenerative Disease
Hugo W. Moser, MD;
Gerald V. Raymond, MD;
Prachi Dubey, MD, MPH
JAMA. 2005;294:3131-3134.
X-linked adrenoleukodystrophy (X-ALD), which was first described in 1923, was viewed until 1976 as a rare and inexorably fatal neurodegenerative disorder that affected boys. The genetic defect and biochemical abnormalities have now been defined. Ongoing research has resulted in new findings: (1) there is a wide range of phenotypic expression. At least half of patients with X-ALD are adults with somewhat milder manifestations, and women who are carriers may become symptomatic. X-ALD is often misdiagnosed as attention-deficit/hyperactivity disorder in boys and as multiple sclerosis in men and women, and is not an uncommon cause of Addison disease; (2) the incidence of X-ALD, estimated to be 1:17 000 in all ethnic groups, approximates that of phenylketonuria; (3) noninvasive and presymptomatic diagnosis and prenatal diagnosis are available; family screening and genetic counseling are key to disease prevention; and (4) new therapies, applied early, show promise. Neonatal screening is likely to become available, and a wider awareness of X-ALD and its various modes of presentation permit new proactive approaches to this distressing disorder.
Author Affliations: Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Md.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
A 63-year-old woman with urinary incontinence and progressive gait disorder
Lossos et al.
Neurology 2009;72:1607-1613.
FULL TEXT
Phenotypes of female adrenoleukodystrophy
Jung et al.
Neurology 2007;68:960-961.
FULL TEXT
|
